CVRx Barostim Therapy clinical trial results to be presented at Heart Rhythm Society 2015


CVRx Barostim Therapy for heart failure clinical trial results have been selected to be presented in the late-breaking clinical trial session of the Heart Rhythm Society 2015 Annual Conference (13–­16 May, Boston, USA).

CVRx has announced that the results from the “Barostim Therapy for heart failure” randomised, controlled clinical trial have been accepted by the Heart Rhythm Society for presentation in the “Late-Breaking Clinical Trial Session II”. Safety and efficacy results comparing patients previously treated with cardiac resynchronisation therapy to patients without cardiac resynchronisation therapy will be presented by Michael Zile from the Medical University of South Carolina, USA, on 15 May from 8–9:30am.